BSE filing, BSE: 544662. Summary written from the filing by ALFA Finder's alert engine.
Simandhar Impex Ltd: key numbers
- Share price
- ₹135.00
- Market cap
- ₹41.27 Cr
- Revenue (annual)
- ₹1.54 Cr
- Net profit (annual)
- ₹0.01 Cr
- P/E (TTM)
- -252.7×Sector 49.5×
- Promoter holding
- 74.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Simandhar Impex Ltd
All →Simandhar Impex Board Meeting Outcome
Simandhar Impex appointed M/s M C Asawa & Co., Chartered Accountants, as Internal Auditor for FY 2026-27, effective 23 October 2026. The filing is a board-approved appointment of an internal audit firm.
- Execution
- Financial year 2026-27
Simandhar Impex Q2 FY27 Results: Net Loss of ₹0.1 Cr
Simandhar Impex Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
Simandhar Impex Management Change
V.K. Surana & Co. resigned as Simandhar Impex's internal auditor effective 21 October 2026. The company will appoint a new internal auditor for FY 2026-27.
Simandhar Impex Board Meeting Date
Simandhar Impex has scheduled a Board meeting for October 23, 2026, to consider H1 and Q2 standalone financial results. No figures are disclosed in this advance notice.
Simandhar Impex Other Announcement
Simandhar Impex Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI disclosure regulations.
Simandhar Impex Capacity Expansion
Simandhar Impex is diversifying its operations by entering new business lines like trading, manufacturing, and logistics, along with functioning as an investment and holding company.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.